The landscape of tumor treatment is constantly evolving, with a growing emphasis on identifying novel therapeutic targets for drug development. Traditional therapies often target rapidly dividing cells, leading to significant side effects. However, the emergence of sophisticated genomic profiling techniques has altered our knowledge of tumor biolog